Omega Therapeutics, Inc. Quarterly Depreciation in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Omega Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q2 2020 to Q3 2024.
  • Omega Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $400K, unchanged year-over-year.
  • Omega Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.84M, a 26.1% increase year-over-year.
  • Omega Therapeutics, Inc. annual Depreciation for 2023 was $1.57M, a 0.26% increase from 2022.
  • Omega Therapeutics, Inc. annual Depreciation for 2022 was $1.56M, a 12.8% increase from 2021.
  • Omega Therapeutics, Inc. annual Depreciation for 2021 was $1.39M, a 21% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.84M $400K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.84M $500K +$200K +66.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.64M $443K +$72K +19.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.57M $497K +$109K +28.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.46M $400K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $1.46M $300K -$100K -25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $1.56M $371K -$5K -1.33% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.56M $388K +$3K +0.78% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.56M $400K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.56M $400K +$100K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.46M $376K +$74K +24.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.39M $385K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $400K +$100K +33.3% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $300K +$100K +50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $302K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 $300K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $200K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.